Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc.
CSE Index:
Currency:
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon Pharmaceuticals Inc. (AGN)
SEDAR Information
Company Info
Address
Suite 1500 - 1055 West Georgia Street
Vancouver, BC V6E4N7
CanadaPhone
604-398-4175Ext
701Email
info@algernonpharmaceuticals.comWebsite
http://algernonpharmaceuticals.comListing date
Monday, February 1, 2016Transfer Agent
TSX Trust CompanyAuditor
Smythe LLPCapitalization
Issued & Outstanding:
9,653,724Reserved for Issuance:
4,968,996Bulletins
01/03/2023
2023-0303 – Stock Split - Algernon Pharmaceuticals Inc. (AGN)
le 1 mars/March 2023
Algernon Pharmaceuticals Inc. has announced a four (4) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive three (3) additional shares for each share held on such date.
CSE Filings
Advertisement
Publicité
